XML 21 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,632,149 $ 1,361,936
Marketable securities 1,144,260 1,149,148
Accounts receivable, net of allowances of $9,001 and $10,635 as of March 31, 2024 and December 31, 2023, respectively 563,865 763,159
Prepaid expenses and other current assets 73,497 64,316
Total current assets 3,413,771 3,338,559
Property and equipment, net 38,160 32,225
Operating lease right-of-use assets 85,069 92,119
Goodwill and intangible assets, net 115,622 117,462
Other assets 14,097 14,040
Total assets 3,666,719 3,594,405
Current liabilities:    
Accounts payable 83,654 79,058
Accrued expenses and other current liabilities 256,229 238,032
Total current liabilities 339,883 317,090
Operating lease liabilities 154,340 160,616
Other liabilities 28,654 26,019
Total liabilities 522,877 503,725
Commitments and contingencies
Stockholders’ equity:    
Class A common stock, $0.00001 par value, 6,666,667 shares authorized, 598,867 and 591,663 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively; Class B common stock, $0.00001 par value, 1,333,333 shares authorized, 83,714 and 86,355 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 7 7
Additional paid-in capital 5,321,530 5,241,954
Accumulated other comprehensive loss (2,615) (1,013)
Accumulated deficit (2,175,080) (2,150,268)
Total stockholders’ equity 3,143,842 3,090,680
Total liabilities and stockholders’ equity $ 3,666,719 $ 3,594,405